Download PDF
1 / Pages

Other users also viewed these articles

Secukinumab as biological treatment for psoriatic arthritis in real clinical practice José A. Pinto Tasende; Francisco J. Maceiras Pan; José A. Mosquera Martínez; Luis Fernández Dominguez; Blanca Correa Rey; Carlos García Porrúa;
Reumatol Clin. 2021;17:203-6
Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice Jordi Gratacós-Masmitja; Emma Beltrán Catalán; José Luis Álvarez Vega; Ana Urruticoechea-Arana; Concepción Fito; Francisco Maceiras; Joaquín María Belzunegui Otano; Julia Fernández Melón; Eugenio Chamizo Carmona; Miguel Ángel Abad Hernández; Inmaculada Ros Vilamajó; Sonia Castro Oreiro; Eva Pascual Alfonso; Juan Carlos Torre Alonso;
Reumatol Clin. 2024;20:24-31
Definition of Remission and Disease Activity Assessment in Psoriatic Arthritis: Evidence and Expert-Based Recommendations Raquel Almodóvar; Juan D. Cañete; Eugenio de Miguel; José Antonio Pinto; Rubén Queiro;
Reumatol Clin. 2021;17:343-50